GlassScriptPhysician profile
Aubree Dalton
NPI 1306624804
$4,908.96
in general payments reported to CMS, 2019-2025
24 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.84 · 2024: $3,719 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,411 · Food and Beverage: $2,371 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,410.78 |
| Food and Beverage | $2,371.19 |
| Education | $126.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,864.73 | 2024-2025 | Urolift, Barrigel |
| Medtronic, INC. | $1,691.66 | 2024-2025 | Interstim |
| Janssen Biotech, INC. | $339.09 | 2024-2025 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $210.41 | 2024-2025 | Keytruda |
| Sumitomo Pharma America, INC. | $77.53 | 2025 | Gemtesa |
| Olympus America INC. | $74.90 | 2024-2025 | Itind System |
| Antares Pharma, INC. | $72.13 | 2024-2025 | Xyosted |
| Astellas Pharma US INC | $59.96 | 2024-2025 | Xtandi |
| Pfizer INC. | $55.16 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $49.22 | 2024 | Provenge |
| Immunitybio, INC. | $48.84 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.37 | 2024 | |
| Srs Medical Systems, INC. | $43.06 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Astrazeneca Pharmaceuticals LP | $40.14 | 2024-2025 | Lynparza |
| Tolmar, INC. | $35.49 | 2025 | Jatenzo, Eligard |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $35.06 | 2024-2025 | Xiaflex |
| Coloplast Corp | $32.82 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $28.42 | 2025 | Personal Catheter Intermittent Catheter |
| Myriad Genetic Laboratories, INC. | $23.84 | 2025 | Prolaris |
| Janssen Scientific Affairs, LLC | $19.70 | 2025 | Erleada |
| Bioprotect Medical, INC. | $18.06 | 2025 | Bioprotect Balloon Implant System |
| Vertex Pharmaceuticals Incorporated | $15.54 | 2025 | |
| 180 Medical, INC. | $14.84 | 2023 | Cure Catheter |
| Alnylam Pharmaceuticals INC. | $13.99 | 2025 | Oxlumo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubree Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.